Published in Int J Nanomedicine on February 14, 2017
Nanotechnology in Sustainable Agriculture: Recent Developments, Challenges, and Perspectives. Front Microbiol (2017) 0.75
Size controlled ultrafine CeO2 nanoparticles produced by the microwave assisted route and their antimicrobial activity. J Mater Sci Mater Med (2017) 0.75
Macromolecular Conjugate and Biological Carrier Approaches for the Targeted Delivery of Antibiotics. Antibiotics (Basel) (2017) 0.75
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis (2015) 40.89
Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci (2004) 9.18
The challenge of new drug discovery for tuberculosis. Nature (2011) 4.23
Amyloid fibers provide structural integrity to Bacillus subtilis biofilms. Proc Natl Acad Sci U S A (2010) 3.78
Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem (2010) 2.72
Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol (2008) 2.54
Structural insight into the biogenesis of β-barrel membrane proteins. Nature (2013) 2.46
Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano (2010) 2.32
Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol (2005) 2.23
Antibacterial properties of nanoparticles. Trends Biotechnol (2012) 2.11
"Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release (2011) 2.03
Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem (2010) 1.79
Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship. ACS Nano (2010) 1.61
Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials (2009) 1.58
Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets. Nat Nanotechnol (2013) 1.51
Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev (2013) 1.49
Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int J Antimicrob Agents (2004) 1.48
What can be inferred from bacterium-nanoparticle interactions about the potential consequences of environmental exposure to nanoparticles? Ecotoxicology (2008) 1.44
Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis. Science (2012) 1.44
Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc (2013) 1.44
New Delhi metallo-ß-lactamase-1 (NDM-1): an emerging threat among Enterobacteriaceae. J Formos Med Assoc (2010) 1.44
Nanodiamond-Gutta Percha Composite Biomaterials for Root Canal Therapy. ACS Nano (2015) 1.42
The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials (2009) 1.33
Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles. ACS Nano (2012) 1.33
Liquid transport facilitated by channels in Bacillus subtilis biofilms. Proc Natl Acad Sci U S A (2012) 1.32
Photocatalytic disinfection using titanium dioxide: spectrum and mechanism of antimicrobial activity. Appl Microbiol Biotechnol (2011) 1.30
Toxicity of ZnO nanoparticles to Escherichia coli: mechanism and the influence of medium components. Environ Sci Technol (2011) 1.27
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm (2013) 1.27
The use of erythromycin and colistin-loaded cement in total knee arthroplasty does not reduce the incidence of infection: a prospective randomized study in 3000 knees. J Bone Joint Surg Am (2013) 1.23
The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli. Biomaterials (2011) 1.18
Emerging themes and therapeutic prospects for anti-infective peptides. Annu Rev Pharmacol Toxicol (2012) 1.15
Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa. Int J Nanomedicine (2012) 1.14
Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res Lett (2014) 1.08
Mechanisms of bacterial biocide and antibiotic resistance. J Appl Microbiol (2002) 1.08
Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano (2012) 1.08
Diffusion of nanoparticles in a biofilm. Environ Sci Technol (2011) 1.07
An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomedicine (2011) 1.07
Hybrid magnetite nanoparticles/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity. Nanoscale Res Lett (2012) 1.05
Food storage material silver nanoparticles interfere with DNA replication fidelity and bind with DNA. Nanotechnology (2009) 1.03
Antibiotic-loaded bone cement reduces deep infection rates for primary reverse total shoulder arthroplasty: a retrospective, cohort study of 501 shoulders. J Shoulder Elbow Surg (2011) 0.99
Photogenerated charge carriers and reactive oxygen species in ZnO/Au hybrid nanostructures with enhanced photocatalytic and antibacterial activity. J Am Chem Soc (2013) 0.99
Involvement of hydrogenases in the formation of highly catalytic Pd(0) nanoparticles by bioreduction of Pd(II) using Escherichia coli mutant strains. Microbiology (2010) 0.95
Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them. Microb Pathog (2016) 0.94
Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles. ACS Appl Mater Interfaces (2013) 0.94
Photogeneration of reactive oxygen species on uncoated silver, gold, nickel, and silicon nanoparticles and their antibacterial effects. Langmuir (2013) 0.94
Emergence of plasmid-mediated colistin resistance (MCR-1) among Escherichia coli isolated from South African patients. S Afr Med J (2016) 0.93
Silver nanoparticles as an alternative strategy against bacterial biofilms. Acta Biochim Pol (2013) 0.93
Photocatalytic antibacterial activity of nano-TiO2 (anatase)-based thin films: effects on Escherichia coli cells and fatty acids. J Photochem Photobiol B (2014) 0.92
Nanoparticles based stem cell tracking in regenerative medicine. Theranostics (2013) 0.91
Antibacterial effect of zinc oxide nanoparticles combined with ultrasound. Nanotechnology (2012) 0.91
Antimicrobial mechanism based on H2O2 generation at oxygen vacancies in ZnO crystals. Langmuir (2013) 0.90
Antibacterial activity and mechanism of Ag-ZnO nanocomposite on S. aureus and GFP-expressing antibiotic resistant E. coli. Colloids Surf B Biointerfaces (2013) 0.90
Fructose-enhanced reduction of bacterial growth on nanorough surfaces. Int J Nanomedicine (2012) 0.90
Fungus-mediated biosynthesis and characterization of TiO₂ nanoparticles and their activity against pathogenic bacteria. Spectrochim Acta A Mol Biomol Spectrosc (2012) 0.90
Eradication of multi-drug resistant bacteria by a novel Zn-doped CuO nanocomposite. Small (2013) 0.90
Therapeutic strategies to combat antibiotic resistance. Adv Drug Deliv Rev (2014) 0.90
Nanoalumina promotes the horizontal transfer of multiresistance genes mediated by plasmids across genera. Proc Natl Acad Sci U S A (2012) 0.90
Silver nanoparticle/chitosan oligosaccharide/poly(vinyl alcohol) nanofibers as wound dressings: a preclinical study. Int J Nanomedicine (2013) 0.88
Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles. Int J Nanomedicine (2012) 0.88
Gold-functionalized magnetic nanoparticles restrict growth of Pseudomonas aeruginosa. Int J Nanomedicine (2014) 0.88
Mechanisms of antibacterial activity of MgO: non-ROS mediated toxicity of MgO nanoparticles towards Escherichia coli. Small (2013) 0.88
Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections. Int J Antimicrob Agents (2014) 0.88
MstX and a putative potassium channel facilitate biofilm formation in Bacillus subtilis. PLoS One (2013) 0.87
Dual effects and mechanism of TiO2 nanotube arrays in reducing bacterial colonization and enhancing C3H10T1/2 cell adhesion. Int J Nanomedicine (2013) 0.87
Silver nanoparticles embedded in zeolite membranes: release of silver ions and mechanism of antibacterial action. Int J Nanomedicine (2011) 0.87
Surface functionalization of thin-film composite membranes with copper nanoparticles for antimicrobial surface properties. Environ Sci Technol (2013) 0.87
Titania nanotubes with adjustable dimensions for drug reservoir sites and enhanced cell adhesion. Mater Sci Eng C Mater Biol Appl (2013) 0.87
Alternative antimicrobial approach: nano-antimicrobial materials. Evid Based Complement Alternat Med (2015) 0.87
Size-controlled dissolution of silver nanoparticles at neutral and acidic pH conditions: kinetics and size changes. Environ Sci Technol (2014) 0.86
Short communication: Carboxylate functionalized superparamagnetic iron oxide nanoparticles (SPION) for the reduction of S. aureus growth post biofilm formation. Int J Nanomedicine (2013) 0.86
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases. Adv Drug Deliv Rev (2013) 0.86
Antibacterial activity of silver and zinc nanoparticles against Vibrio cholerae and enterotoxic Escherichia coli. Int J Med Microbiol (2014) 0.84
An investigation into the effects of silver nanoparticles on antibiotic resistance of naturally occurring bacteria in an estuarine sediment. Mar Environ Res (2009) 0.84
A novel antibacterial modification treatment of titanium capable to improve osseointegration. Int J Artif Organs (2012) 0.83
Dual-responsive polymer coated superparamagnetic nanoparticle for targeted drug delivery and hyperthermia treatment. ACS Appl Mater Interfaces (2015) 0.83
Interactive effects of copper oxide nanoparticles and light to green alga Chlamydomonas reinhardtii. Aquat Toxicol (2015) 0.83
Bacteria-responsive multifunctional nanogel for targeted antibiotic delivery. Adv Mater (2012) 0.83
The Antibacterial Activity of Ta-doped ZnO Nanoparticles. Nanoscale Res Lett (2015) 0.83
Bactericidal activity of partially oxidized nanodiamonds. ACS Nano (2014) 0.83
Nanoparticle approaches against bacterial infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2014) 0.83
A novel study of antibacterial activity of copper iodide nanoparticle mediated by DNA and membrane damage. Colloids Surf B Biointerfaces (2012) 0.83
Insight into the primary mode of action of TiO2 nanoparticles on Escherichia coli in the dark. Proteomics (2014) 0.82
Significance of postgrowth processing of ZnO nanostructures on antibacterial activity against gram-positive and gram-negative bacteria. Int J Nanomedicine (2015) 0.82
Tripartite assembly of RND multidrug efflux pumps. Nat Commun (2016) 0.82
Synthesis and characterization of the antibacterial potential of ZnO nanoparticles against extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated from a tertiary care hospital of North India. Appl Microbiol Biotechnol (2011) 0.82
Comprehensive screening of genes resistant to an anticancer drug in esophageal squamous cell carcinoma. Int J Oncol (2015) 0.81
Potent antibacterial nanoparticles for pathogenic bacteria. ACS Appl Mater Interfaces (2015) 0.81
Mesoporous titanium dioxide coating for metallic implants. J Biomed Mater Res B Appl Biomater (2011) 0.81
Mechanisms and consequences of bacterial resistance to antimicrobial peptides. Drug Resist Updat (2016) 0.81
Magnetic nanoparticles and rapamycin encapsulated into polymeric nanocarriers. J Biomed Nanotechnol (2012) 0.81
Potent antimicrobial activity of bone cement encapsulating silver nanoparticles capped with oleic acid. J Biomed Mater Res B Appl Biomater (2014) 0.81
Antibacterial Effects of Biosynthesized Silver Nanoparticles on Surface Ultrastructure and Nanomechanical Properties of Gram-Negative Bacteria viz. Escherichia coli and Pseudomonas aeruginosa. ACS Appl Mater Interfaces (2016) 0.80
Inhibition of gold nanoparticles (AuNPs) on pathogenic biofilm formation and invasion to host cells. Sci Rep (2016) 0.80
The role of nanotechnology in combating multi-drug resistant bacteria. J Nanosci Nanotechnol (2014) 0.80
Controlled synthesis of Ag nanoparticles with different morphologies and their antibacterial properties. Mater Sci Eng C Mater Biol Appl (2012) 0.80
Antimicrobial activity of iron oxide nanoparticle upon modulation of nanoparticle-bacteria interface. Sci Rep (2015) 0.80
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application. Adv Pharm Bull (2015) 0.80
Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant bacteria. J Nanobiotechnology (2015) 0.79
Antimicrobial surfaces containing cationic nanoparticles: how immobilized, clustered, and protruding cationic charge presentation affects killing activity and kinetics. Colloids Surf B Biointerfaces (2014) 0.79
Synthesis and anti-staphylococcal activity of TiO2 nanoparticles and nanowires in ex vivo porcine skin model. J Biomed Nanotechnol (2014) 0.79
Involvement of PINK1/parkin-mediated mitophagy in ZnO nanoparticle-induced toxicity in BV-2 cells. Int J Nanomedicine (2017) 0.75
The mechanisms of graphene-based materials-induced programmed cell death: a review of apoptosis, autophagy, and programmed necrosis. Int J Nanomedicine (2017) 0.75